1. Home
  2. INSM vs KR Comparison

INSM vs KR Comparison

Compare INSM & KR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • KR
  • Stock Information
  • Founded
  • INSM 1988
  • KR 1883
  • Country
  • INSM United States
  • KR United States
  • Employees
  • INSM N/A
  • KR N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • KR Food Chains
  • Sector
  • INSM Health Care
  • KR Consumer Staples
  • Exchange
  • INSM Nasdaq
  • KR Nasdaq
  • Market Cap
  • INSM 41.2B
  • KR 44.8B
  • IPO Year
  • INSM 2000
  • KR N/A
  • Fundamental
  • Price
  • INSM $206.24
  • KR $67.20
  • Analyst Decision
  • INSM Strong Buy
  • KR Buy
  • Analyst Count
  • INSM 19
  • KR 15
  • Target Price
  • INSM $173.35
  • KR $73.73
  • AVG Volume (30 Days)
  • INSM 3.0M
  • KR 6.5M
  • Earning Date
  • INSM 10-30-2025
  • KR 12-04-2025
  • Dividend Yield
  • INSM N/A
  • KR 2.09%
  • EPS Growth
  • INSM N/A
  • KR 2.66
  • EPS
  • INSM N/A
  • KR 3.92
  • Revenue
  • INSM $447,022,000.00
  • KR $147,000,000,000.00
  • Revenue This Year
  • INSM $40.09
  • KR $4.06
  • Revenue Next Year
  • INSM $129.64
  • KR $2.85
  • P/E Ratio
  • INSM N/A
  • KR $17.09
  • Revenue Growth
  • INSM 30.34
  • KR N/A
  • 52 Week Low
  • INSM $60.40
  • KR $57.69
  • 52 Week High
  • INSM $209.77
  • KR $74.90
  • Technical
  • Relative Strength Index (RSI)
  • INSM 70.57
  • KR 54.55
  • Support Level
  • INSM $194.65
  • KR $64.26
  • Resistance Level
  • INSM $209.77
  • KR $68.36
  • Average True Range (ATR)
  • INSM 6.85
  • KR 1.36
  • MACD
  • INSM 0.15
  • KR 0.19
  • Stochastic Oscillator
  • INSM 86.77
  • KR 77.20

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About KR Kroger Company (The)

Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of over 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.

Share on Social Networks: